Event Details Oral Small Molecule Hepatocyte Growth Factor/MET Positive Modulator ATH-1020 Reduces Depression-like Behaviors and Normalizes Pathological EEG Mismatch Negativity in Preclinical Models March 2, 2022 Supporting Materials View Presentation 1 MB View Video < SIGN UP FOR EMAIL ALERTS CONTACT IR
Oral Small Molecule Hepatocyte Growth Factor/MET Positive Modulator ATH-1020 Reduces Depression-like Behaviors and Normalizes Pathological EEG Mismatch Negativity in Preclinical Models March 2, 2022 Supporting Materials View Presentation 1 MB View Video
